First-in-human phase I study of CEB-01, a biodegradable SN-38–releasing membrane, to prevent local recurrence after resection of retroperitoneal sarcoma: Updated results.
José González-Lopez, Ana Sebio, Javier Martín Broto, Nadia Hindi et autres
es (code pays fourni par la source)
0 citations
Journal of Clinical Oncology